Apparent Life-Threatening Events 

  • Author: Patrick L Carolan, MD; Chief Editor: Michael R Bye, MD   more...
 
Updated: Jul 15, 2011
 

Overview

According to the National Institutes of Health:[1]

An apparent life-threatening event (ALTE) is defined as an episode that is frightening to the observer and is characterized by some combination of apnea (central or obstructive), color change (cyanotic, pallid, erythematous or plethoric) change in muscle tone (usually diminished), and choking or gagging. In some cases, the observer fears that the infant has died. Previously used terminology such as near-miss sudden infant death syndrome (SIDS) or aborted crib death should be abandoned because their use implies a possibly misleading close association between this type of spell and SIDS.

This description was established by expert consensus in 1986 and remains the standard clinical definition.

Next

Epidemiology

  • Because of marked variability in the clinical presentations of apparent life-threatening events (ALTEs), the true frequency is unknown.
  • The estimated frequency of apparent life-threatening events among healthy term infants widely varies (0.5–6% of all newborns), reflecting figures derived from older retrospective reviews of hospital records.[2]
  • A systematic review reported that apparent life-threatening events accounted for 0.6-0.8% of all emergency department visits among children younger than 1 year, was noted in 2.27% of hospitalized children, and had an incidence of 0.6 cases per 1,000 live-born infants.[3]
  • A prospective population-based study of apparent life-threatening events conducted in Austria reported an incidence of 2.46 cases per 1,000 live births.[4]
  • Esani et al (2008) compared the epidemiologic features of apparent life-threatening events and sudden infant death syndrome (SIDS).[5]
    • Infants who experienced an apparent life-threatening event were younger at the time of clinical presentation.
    • In this study, 74% of patients who experienced an apparent life-threatening event presented when younger than 2 months. By contrast, approximately 25% of SIDS victims are younger than 2 months at the time of death, according to several epidemiologic studies of SIDS.
    • The apparent life-threatening event cohort also included more female infants and fewer infants who were small for gestational age and who had low birth weight when compared with infants who experienced SIDS in other studies. The risk of subsequent death in the apparent life-threatening event group was 0.6%.
Previous
Next

Differential Diagnosis

The cause of apparent life-threatening events (ALTEs) in infants reflects a differential diagnosis that includes an array of congenital or acquired disorders. As many as 50% of apparent life-threatening events may remain unexplained following a thorough evaluation.

  • From retrospective studies, apparent life-threatening events have been associated with gastroesophageal reflux disease; viral lower respiratory tract infection; pertussis; sepsis and/or meningitis; seizures; metabolic disorders; cardiac dysrhythmia (eg, long QT syndrome, supraventricular tachycardia); anemia; nonaccidental trauma; or structural CNS, cardiac (ductal-dependent lesion), or airway anomaly.
  • Davies and Gupta (2002) conducted a prospective study of infants who presented to an emergency department with an apparent life-threatening event over a 1-year period.[6] The results of this prospective study suggest that a standardized approach to evaluation identifies a specific cause in most presentations. Each infant was subject to a standardized evaluation protocol upon admission; only 23% of patients had no diagnosis after evaluation. The apparent life-threatening events were associated with the following:
    • Gastroesophageal reflux disease - 26%
    • Pertussis - 9%
    • Lower respiratory tract infection - 9%
    • Seizure - 9%
    • Urinary tract infection - 8%
    • Factitious illness - 3%
    • Miscellaneous - 11%
  • Parker and Pitetti (2011) reviewed the children presenting to an emergency department of a large children’s hospital with a diagnosis of ALTE, looking at follow up mortality. They found a mortality rate of 0.5%; however, in those children who were victims of nonaccidental trauma, the subsequent mortality rate was 9%.[7]
Previous
Next

Clinical Evaluation

The evaluation and disposition of an infant following an apparent life-threatening event (ALTE) is directed by a thorough history of the event and a careful physical examination. In most cases, the infant is free of symptoms by the time medical evaluation occurs, allowing for a systematic approach to history-taking and physical examination.

History

Key questions related to the history of the episode include the following:

  • Who observed the event? Recognize that second-hand accounts may vary from the history provided by direct observers who were present at the time.
  • What was the description of the event? A caregiver’s description of the infants’ color, respiration, and muscle tone is key. Care must be taken to distinguish central cyanosis (lips and oral mucous membranes) from acrocyanosis (hands and feet). Infants who are coughing, choking, or gagging may exhibit a ruddy or plethoric facial color that may be interpreted as “turning blue.” Determine whether apnea was present, and, if so, whether it appeared to be central (lack of respiratory effort) or obstructive (respiratory effort with inadequate airflow). Distinguish apnea that lasted more than 15-20 seconds from periodic breathing, in which respiratory rate and tidal volumes fluctuate and are accompanied by brief pauses in breathing that typically last less than 5-10 seconds.
  • Was the infant limp, or was muscle tone increased during or after the event?
  • Were any seizurelike movements observed?
  • Was any resuscitation required, or did the event spontaneously resolve? Recall that caregivers may provide mouth-to-mouth resuscitation to spontaneously breathing infants with intact perfusion, fearing that the infant’s life is threatened.
  • Was the infant born at term, or was the infant premature?
  • Were any pregnancy or labor and delivery complications reported?
  • Are any factors that predispose to neonatal sepsis noted?
  • Has the infant previously exhibited symptoms of gastroesophageal reflux or aspiration of thin liquids? These symptoms may include coughing, choking, or gagging during or after feeding; frequent or excessive spitting-up; persistent nasal stuffiness; or frequent hiccups. Acid reflux disease is suggested by excessive irritability, arching, and straining behaviors displayed during or following a feeding.
  • Are the newborn metabolic screening findings normal?
  • Does the family have a history of seizures, metabolic disorders, previous sudden infant death syndrome (SIDS), or unexplained death in infancy or childhood?

Physical examination

A complete physical examination begins by obtaining a full set of vital signs, including pulse oximetry.

  • A full head-to-toe examination of the skin should be performed to look for skin lesions or signs of trauma.
  • The head and neck examination should note the characteristics of the anterior fontanelle (ie, normal, bulging, or sunken). Nondilated funduscopic examination should be performed. If retinal hemorrhages are suspected, a formal dilated indirect examination may be necessary for further characterization.[8] The nose and mouth should be examined for the presence of blood or formula.
  • The respiratory examination should include the respiratory rate, pattern of breathing, and adequacy of air exchange. The presence of stridor, wheezes, or crackles should be noted.
  • The cardiovascular examination should reveal whether murmurs are present and the adequacy and symmetry of pulses. In young infants, suspicion for ductal-dependent cardiovascular lesions may be heralded by a differential in blood pressure findings, oximetry findings, or both in the right upper extremity compared with measurements obtained from the lower extremities.
  • Abdominal distension or tenderness may indicate acute intestinal obstruction. Inguinoscrotal examination should evaluate for incarcerated inguinal hernia or testicular torsion.
  • Neurologic assessment begins with assessment of the infants’ responsiveness. Determine whether lethargy is persistent or resolved and whether the muscle tone and reflexes are appropriate for age. Also, determine if any focal or lateralizing findings are present.
  • The skin should be carefully examined for bruises. The bones should be carefully palpated for signs of trauma.
Previous
Next

Laboratory Evaluation

  • The laboratory evaluation of an infant following an apparent life-threatening event (ALTE) is directed by a thorough history of the event and careful physical examination.
  • Altman et al (2007) noted that signs or symptoms indicative of acute infection are typically present among infants with apparent life-threatening events who are subsequently shown to have bacterial infection.[9] However, in this study, some infants with urinary tract infection or pneumonia lacked conventional signs or symptoms, suggesting the need to consider these types of infections in infants with apparent life threatening events.
  • Zuckerbraun et al (2009) determined that serious bacterial infections (SBIs) occurred in 2.7% of afebrile, well-appearing infants younger than 60 days who experienced an apparent life-threatening event.[10] Infants with a history of prematurity were more likely to have an SBI than infants born at term (6.7% vs 0.8%; P = 0.04), suggesting the need for added vigilance in screening premature infants for SBI following an apparent life-threatening event.
  • Diagnostic evaluation may include the following:
    • A CBC count to screen for the presence of systemic viral or bacterial infection or anemia[11]
    • Serum chemistry levels to assess for hypoglycemia, hyponatremia, hyperkalemia, acidemia, hypocalcemia, or elevation of serum lactate
    • ABG to assess for acidosis or retention of carbon dioxide
    • Serum or urine toxicology studies for suspected ingestions
    • Specific bacterial or viral cultures to assess for respiratory syncytial virus (RSV), pertussis, bacteremia, or urinary tract infection
    • ECG to assess for long QT syndrome and preexcitation that suggests supraventricular tachycardia or other dysrhythmia
    • EEG to assess for epileptiform activity
    • Upper GI contrast studies to assess for swallowing dysfunction, thin liquid aspiration, or upper-intestinal anatomic malformations
    • Impedance pH monitoring to assess for gastroesophageal reflux disease
    • Neuroimaging to assess for hemorrhage or structural CNS abnormality
    • Polysomnography to assess for sleep-based disturbances in cardiorespiratory control
Previous
Next

Disposition

  • In-hospital observation has been suggested for most infants following an apparent life-threatening event (ALTE). The initial evaluation of some infants reveals active ongoing symptoms and clearly suggests the need for hospitalization for further evaluation and treatment (eg, sepsis). However, apparent life-threatening events that are the result of self-resolving episodes of choking or gagging associated with feedings in well-appearing infants may be observed in an outpatient setting.
  • Claudius and Keens (2007) noted that infants who were younger than 1 month at the time of presentation or who had a history of recurrent apparent life-threatening events were at high risk for eventual diagnoses that required further in-hospital evaluation.[12] This study suggests that well-appearing infants older than 30 days who have experienced a single apparent life-threatening event and who have normal initial screening findings may be safely discharged from the hospital with proper outpatient follow-up.
  • Documenting cardiorespiratory monitors may be considered for preterm infants who are at high risk for recurrent apnea or bradycardia and for infants who depend on technology due to specific disorders of cardiorespiratory control.[13]
Previous
 
Contributor Information and Disclosures
Author

Patrick L Carolan, MD  Adjunct Associate Professor, Departments of Pediatrics, Family Practice, and Community Health, University of Minnesota Medical School; Medical Director of Minnesota Sudden Infant Death Center; Attending Staff, Department of Emergency Services, Children's Hospitals and Clinics of Minnesota

Patrick L Carolan, MD is a member of the following medical societies: American Academy of Pediatrics and International Society of SIDS Researchers

Disclosure: Nothing to disclose.

Specialty Editor Board

Susanna A McColley, MD  Professor of Pediatrics, Northwestern University, The Feinberg School of Medicine; Director of Cystic Fibrosis Center, Head, Division of Pulmonary Medicine, Children's Memorial Medical Center of Chicago

Susanna A McColley, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Sleep Disorders Association, and American Thoracic Society

Disclosure: Genentech Honoraria Speaking and teaching; Genentech Honoraria Consulting; Boston Scientific Consulting fee Consulting; Gilead Honoraria Speaking and teaching; Caremark Consulting fee Consulting; Vertex Pharmaceuticals Honoraria Speaking and teaching

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Mary E Cataletto, MD  Director of Children's Sleep Services, Winthrop Sleep Disorders Center, Mineola, NY; Professor of Clinical Pediatrics, State University of New York at Stony Brook, Stony Brook, NY

Mary E Cataletto, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Chest Physicians

Disclosure: Shering Plough Pharmaceuticals Honoraria Consulting

Chief Editor

Michael R Bye, MD  Professor of Clinical Pediatrics, Division of Pulmonary Medicine, Columbia University College of Physicians and Surgeons; Attending Physician, Pediatric Pulmonary Medicine, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center

Michael R Bye, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, and American Thoracic Society

Disclosure: Nothing to disclose.

References
  1. National Institute of Health. Infantile apnea and home monitoring. Natl Inst Health Consens Dev Conf Consens Statement. Oct 1 1986;6(6):1-10. [Medline].

  2. Brooks JG. Apparent life-threatening events and apnea of infancy. Clin Perinatol. Dec 1992;19(4):809-38. [Medline].

  3. McGovern MC, Smith MB. Causes of apparent life threatening events in infants: a systematic review. Arch Dis Child. Nov 2004;89(11):1043-8. [Medline].

  4. Kiechl-Kohlendorfer U, Hof D, Peglow UP, Traweger-Ravanelli B, Kiechl S. Epidemiology of apparent life threatening events. Arch Dis Child. Mar 2005;90(3):297-300. [Medline].

  5. Esani N, Hodgman J, Ehsani N, Hoppenbrousers T. Apparent Life-Threatening Events and Sudden Infant Death Syndrome: A Comparison of RIsk Factors. Journal of Pediatrics. March 2008;152:365-70. [Medline].

  6. Davies F, Gupta R. Apparent life threatening events in infants presenting to an emergency department. Emerg Med J. Jan 2002;19(1):11-6. [Medline].

  7. Parker K, Pitetti R. Mortality and child abuse in children presenting with apparent life-threatening events. Pediatr Emerg Care. Jul 2011;27(7):591-5. [Medline].

  8. Altman RL, Forman S, Brand DA. Ophthalmologic findings in infants after an apparent life-threatening event. Eur J Ophthalmol. Jul-Aug 2007;17(4):648-53. [Medline].

  9. Altman RL, Li KI, Brand DA. Infections and apparent life-threatening events. Clin Pediatr (Phila). May 2008;47(4):372-8. [Medline].

  10. Zuckerbraun NS, Zomorrodi A, Pitetti RD. Occurrence of serious bacterial infection in infants aged 60 days or younger with an apparent life-threatening event. Pediatr Emerg Care. Jan 2009;25(1):19-25. [Medline].

  11. Pitetti RD, Lovallo A, Hickey R. Prevalence of anemia in children presenting with apparent life-threatening events. Acad Emerg Med. Oct 2005;12(10):926-31. [Medline].

  12. Claudius I, Keens T. Do all infants with apparent life-threatening events need to be admitted?. Pediatrics. Apr 2007;119(4):679-83. [Medline].

  13. Fu LY, Moon RY. Apparent life-threatening events (ALTEs) and the role of home monitors. Pediatr Rev. Jun 2007;28(6):203-8. [Medline].

  14. Altman RL, Brand DA, Forman S, Kutscher ML, Lowenthal DB, Franke KA. Abusive head injury as a cause of apparent life-threatening events in infancy. Arch Pediatr Adolesc Med. Oct 2003;157(10):1011-5. [Medline].

  15. Brand DA, Altman RL, Purtill K, Edwards KS. Yield of diagnostic testing in infants who have had an apparent life-threatening event. Pediatrics. Apr 2005;115(4):885-93. [Medline].

  16. Brooks JG. Apparent life-threatening events. Pediatr Rev. Jul 1996;17(7):257-9. [Medline].

  17. Committee on Fetus and Newborn. American Academy of Pediatrics. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics. Apr 2003;111(4 Pt 1):914-7. [Medline].

  18. Cote A. Home and hospital monitoring for ALTE. Paediatr Respir Rev. 2006;7 Suppl 1:S199-201. [Medline].

  19. De Piero AD, Teach SJ, Chamberlain JM. ED evaluation of infants after an apparent life-threatening event. Am J Emerg Med. Mar 2004;22(2):83-6. [Medline].

  20. Dewolfe CC. Apparent life-threatening event: a review. Pediatr Clin North Am. Aug 2005;52(4):1127-46, ix. [Medline].

  21. Edner A, Wennborg M, Alm B, Lagercrantz H. Why do ALTE infants not die in SIDS?. Acta Paediatr. Feb 2007;96(2):191-4. [Medline].

  22. Gershan WM, Besch NS, Franciosi RA. A comparison of apparent life-threatening events before and after the back to sleep campaign. WMJ. 2002;101(1):39-45. [Medline].

  23. Gozal D. New concepts in abnormalities of respiratory control in children. Curr Opin Pediatr. Jun 2004;16(3):305-8. [Medline].

  24. Gray C, Davies F, Molyneux E. Apparent life-threatening events presenting to a pediatric emergency department. Pediatr Emerg Care. Jun 1999;15(3):195-9. [Medline].

  25. Grylack LJ, Williams AD. Apparent life-threatening events in presumed healthy neonates during the first three days of life. Pediatrics. Mar 1996;97(3):349-51. [Medline].

  26. Hall KL, Zalman B. Evaluation and management of apparent life-threatening events in children. Am Fam Physician. Jun 15 2005;71(12):2301-8. [Medline].

  27. Miyagawa T, Sotero M, Avellino AM, et al. Apnea caused by mesial temporal lobe mass lesions in infants: report of 3 cases. J Child Neurol. Sep 2007;22(9):1079-83. [Medline].

  28. Naulaers G, Daniels H, Allegaert K, Rayyan M, Debeer A, Devlieger H. Cardiorespiratory events recorded on home monitors: the effect of prematurity on later serious events. Acta Paediatr. Feb 2007;96(2):195-8. [Medline].

  29. Poets CF. Apparent life-threatening events and sudden infant death on a monitor. Paediatr Respir Rev. 2004;5 Suppl A:S383-6. [Medline].

  30. Reix P, St-Hilaire M, Praud JP. Laryngeal sensitivity in the neonatal period: from bench to bedside. Pediatr Pulmonol. Aug 2007;42(8):674-82. [Medline].

  31. Semeniuk J, Kaczmarski M, Wasilewska J, Nowowiejska B. Is acid gastroesophageal reflux in children with ALTE etiopathogenetic factor of life threatening symptoms?. Adv Med Sci. 2007;52:213-21. [Medline].

  32. Shah S, Sharieff GQ. An update on the approach to apparent life-threatening events. Curr Opin Pediatr. Jun 2007;19(3):288-94. [Medline].

  33. Stratton SJ, Taves A, Lewis RJ, Clements H, Henderson D, McCollough M. Apparent life-threatening events in infants: high risk in the out-of-hospital environment. Ann Emerg Med. Jun 2004;43(6):711-7. [Medline].

  34. Tirosh E, Jaffe M. Apparent life-threatening event: a neurologic perspective. J Child Neurol. May 1995;10(3):216-8. [Medline].

  35. Warren J, Biagioli F, Hamilton A, Smith PC. FPIN's clinical inquiries. Evaluation of apparent life-threatening events in infants. Am Fam Physician. Jul 1 2007;76(1):124-6. [Medline].

  36. Waseem M, Pinkert H. Apparent life-threatening event or child abuse?. Pediatr Emerg Care. Apr 2006;22(4):245-6. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.